NO20004668L - 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister - Google Patents

1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister

Info

Publication number
NO20004668L
NO20004668L NO20004668A NO20004668A NO20004668L NO 20004668 L NO20004668 L NO 20004668L NO 20004668 A NO20004668 A NO 20004668A NO 20004668 A NO20004668 A NO 20004668A NO 20004668 L NO20004668 L NO 20004668L
Authority
NO
Norway
Prior art keywords
benzylpiperidines
heteroarylpropyl
enyl
prop
receptor antagonists
Prior art date
Application number
NO20004668A
Other languages
English (en)
Other versions
NO20004668D0 (no
Inventor
Helmut Pruecher
Andrew Barber
Joachim Leibrock
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20004668L publication Critical patent/NO20004668L/no
Publication of NO20004668D0 publication Critical patent/NO20004668D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Piperidinderivater med formel (I) samt fysiologisk akseptable salter derav, hvor X, Y, Z, R1, R2, R3 og R4 har de i krav l angitte betydninger, kan anvendes som eksitatoriske aminosyreantagonister til bekjempelse av neurodegenerarive sykdommer, inkludert cerebrovaskulære sykdommer, epilepsi, schizofreni, Alzheimers, Parkinsons eller Huntingtons sykdom, cerebrale iskemier, infarkt eller psykoser.
NO20004668A 1998-03-20 2000-09-19 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister NO20004668D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812331A DE19812331A1 (de) 1998-03-20 1998-03-20 Piperidinderivate
PCT/EP1999/001573 WO1999048891A1 (de) 1998-03-20 1999-03-11 1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4-benzylpiperidine als nmda-rezeptor-antagonisten

Publications (2)

Publication Number Publication Date
NO20004668L true NO20004668L (no) 2000-09-19
NO20004668D0 NO20004668D0 (no) 2000-09-19

Family

ID=7861717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004668A NO20004668D0 (no) 1998-03-20 2000-09-19 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister

Country Status (22)

Country Link
US (1) US6548516B1 (no)
EP (1) EP1068202B1 (no)
JP (1) JP4451565B2 (no)
KR (1) KR20010042047A (no)
CN (1) CN1123571C (no)
AR (1) AR014747A1 (no)
AT (1) ATE416173T1 (no)
AU (1) AU747900B2 (no)
BR (1) BR9908902A (no)
CA (1) CA2324339C (no)
DE (2) DE19812331A1 (no)
DK (1) DK1068202T3 (no)
ES (1) ES2316184T3 (no)
HU (1) HUP0101220A3 (no)
ID (1) ID26125A (no)
NO (1) NO20004668D0 (no)
PL (1) PL342732A1 (no)
PT (1) PT1068202E (no)
RU (1) RU2217429C2 (no)
SK (1) SK13692000A3 (no)
WO (1) WO1999048891A1 (no)
ZA (1) ZA992191B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011926A (es) 2000-05-31 2003-04-22 Warner Lambert Co Ciclohexilaminas biciclicas y su uso como antagonistas de receptor de n-metil-d-aspartato.
BR0111267A (pt) * 2000-06-06 2003-12-16 Warner Lambert Co Cicloexilaminas bicìclicas e seu uso como antagonistas do receptor de nmda
AU2002223968A1 (en) 2000-12-21 2002-07-01 Warner Lambert Company Llc Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
MXPA02002749A (es) 2001-03-27 2002-10-28 Warner Lambert Co Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato.
DE10248067A1 (de) * 2002-10-07 2004-04-15 Proteosys Ag Heteroarylpropyl-Piperazine und Heteroarylpropyl-Piperidine
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (ja) 2006-11-30 2014-06-18 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
AU2010331949A1 (en) * 2009-12-15 2012-07-12 Neurop, Inc. Compounds for the treatment of neurologic disorders
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
CN102133198B (zh) * 2011-03-09 2012-02-08 北京四环科宝制药有限公司 一种酒石酸艾芬地尔冻干粉针剂及其制备方法
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
ES2767707T3 (es) * 2015-04-29 2020-06-18 Janssen Pharmaceutica Nv Compuestos de indolona y su uso como moduladores de receptor AMPA
HRP20210403T1 (hr) 2015-04-29 2021-10-29 Janssen Pharmaceutica Nv Azabenzimidazoli i njihova uporaba kao modulatora ampa receptora
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JP3084729B2 (ja) * 1990-06-15 2000-09-04 横河電機株式会社 デジタルオシロスコープ
TW281670B (no) * 1993-09-02 1996-07-21 Hoffmann La Roche
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1996002250A1 (en) * 1994-07-20 1996-02-01 Acea Pharmaceuticals Inc. Haloperidol analogs and the use thereof
DE59504622D1 (de) * 1994-10-31 1999-02-04 Merck Patent Gmbh Benzylpiperidinderivate mit hoher Affinität zu Bindungsstellen von Aminosäure-Rezeptoren
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
DE19643790A1 (de) * 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat

Also Published As

Publication number Publication date
KR20010042047A (ko) 2001-05-25
CN1293673A (zh) 2001-05-02
DE19812331A1 (de) 1999-09-23
JP2002507613A (ja) 2002-03-12
AR014747A1 (es) 2001-03-28
EP1068202A1 (de) 2001-01-17
ID26125A (id) 2000-11-23
AU3410599A (en) 1999-10-18
PL342732A1 (en) 2001-07-02
WO1999048891A1 (de) 1999-09-30
CA2324339C (en) 2010-01-12
PT1068202E (pt) 2009-03-06
AU747900B2 (en) 2002-05-30
RU2217429C2 (ru) 2003-11-27
HUP0101220A2 (hu) 2002-05-29
CN1123571C (zh) 2003-10-08
BR9908902A (pt) 2000-11-28
EP1068202B1 (de) 2008-12-03
DK1068202T3 (da) 2009-03-16
ZA992191B (en) 1999-09-29
HUP0101220A3 (en) 2003-08-28
CA2324339A1 (en) 1999-09-30
SK13692000A3 (sk) 2001-02-12
JP4451565B2 (ja) 2010-04-14
ATE416173T1 (de) 2008-12-15
ES2316184T3 (es) 2009-04-01
US6548516B1 (en) 2003-04-15
DE59914921D1 (de) 2009-01-15
NO20004668D0 (no) 2000-09-19

Similar Documents

Publication Publication Date Title
AU2003224064A1 (en) Substituted indoles
CY1108674T1 (el) Κυκλικα αμιδια
DE60212836T2 (de) Pyridylpyrimidin-derivate als wirksame verbindungen gegen prionen-krankheiten
HUP0302385A2 (hu) Új többgyűrűs vegyületek és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
DE69926254D1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
NO20064726L (no) Imidazolforbindelser for behandling av neurodegenerative forstyrrelser
CY1107401T1 (el) Παραγωγα βενζοθειαζολιου πα την θεραπευτικη αντιμετωπιση της νοσου alzheimer και της νοσου parkinson
CA2104909A1 (en) Decahydroisoquinolines as excitatory amino acid receptor antagonists
NO20051689L (no) Substituerte piperaziner, (1,4) diaszepiner og 2,5-diazabicyklo(2.2.1) heptaner som histamin H1 og/eller H3 antagonister eller histamin H3 revers antagonister
UY28103A1 (es) Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
NO178262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler
TW200502221A (en) Novel lactams and uses thereof
CA2379026A1 (en) Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
BR9908902A (pt) Derivados de piperidina
DE60038686D1 (de) Oheptan-derivate und ihre verwendung als integrin-rezeptor-antagonisten
WO1992020649A3 (en) Substituted 2-carboxyindoles having pharmaceutical activity
MY149422A (en) 5-(arylsulfonyl)-pyrazolopiperidines
ATE283265T1 (de) 8,8a-dihydro-indeno (1,2-d)thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
ATE334965T1 (de) Piperidinverbindungen als muscarinantagonisten
NO20015247L (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
NO20001049L (no) Kondenserte tiofenforbindelser og farmasøytisk anvendelse derav
NO981383L (no) Benzyloksysubstituerte, kondenserte N-heterocykluser, fremgangsmåter for deres fremstilling og deres anvendelse som bradykininreseptorantagonister
NO992063L (no) Benzoksazolderivat med affinitet til bindingssteder pÕ aminosyrereseptorer
ATE449082T1 (de) (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl) amine mit aktivität am 5-ht-rezeptor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application